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Abstract 
BACKGROUND: Primary mediastinal seminomas most commonly occur in young men, and they are localised in 
the anterior mediastinum.  
CASE PRESENTATION: The presented study is a case report of a 34-year-old man suffering from a mediastinal 
tumour in size of 19 cm, with pleural and pericardial effusion. The patient complains of cough, difficulty breathing, 
weight loss, and pronounced tiredness. CT of lungs and biopsy of the mediastinal change was performed. The 
histopathological analysis was in favour of a primary mediastinal seminoma. The patient initially had pronouncedly 
increased levels of LDH and β-hCG tumour marker. Pericardiocentesis was realised due to threatening 
tamponade of the heart, followed by 4 cycles of chemotherapy by BEP protocol. Following 2 cycles of 
chemotherapy, normalisation of LDH and β-HCG levels and significantly improved the clinical condition in the 
patient was found. Upon completion of 4 chemotherapy cycles by BEP protocol, the patient performed an FDG-
PET scan with partial response and reduced dimension of a primary tumour in the mediastinum. Radiotherapy of 
residual tumour mass up to a total dose of 40Gy in 20 fractions was realised. Control FDG-PET scan had a 
finding of complete response to a tumour and absence of FDG uptake. The last follow-up examination was 
performed in October 2018, and the patient was disease-free for 54 months. 
CONCLUSION: Multimodality treatment approach of chemotherapy followed by radiation consolidation ensured 
long-term survival in primary advanced mediastinal seminoma. 
 
 
 
 
 
 
 
Introduction 
 
Primary extragonadal germ cell tumours occur 
rarely, and they include 1-5% of all germ cell 
malignancies [1]. The most common extragonadal 
localisations are mediastinum and retroperitoneum. 
Primary mediastinal germ cell tumours are rare 
lesions accounting for only 10-15% of mediastinal 
masses. Most of these tumours are benign lesions; 
however, up to one-third of them could be malignant, 
and seminoma is the most common histologic 
subtype. The primary mediastinal seminoma is a rare 
tumour. In general terms, mediastinal seminomas are 
bulky tumours, and they tend to infiltrate into adjacent 
structures early in the growth process. Pure 
seminoma is sensitive to chemotherapy and 
radiotherapy, and the prognosis is good [2]. These 
tumours typically occur in men from the second to the 
fourth decade of life and could be present as 
asymptomatic, incidentally discovered lesions in 20-
30% of patients. 
Case Presentation 
 
A 34-year-old patient was diagnosed with 
chest pain lasting for 2-3 months. Due to pain 
progression, the occurrence of pronounced fatigue, 
cough and body weight loss (more than 15 kg), X-ray 
of lungs was performed with a finding of mediastinal 
tumour mass, and consequently, CT of lungs was 
performed by intravenous application of contrast. CT 
finding of lungs was in favour of a large expansive 
process in the mediastinum, with irregular form and 
lobular contours and dimensions of 190 x 100 x 175 
mm.  
The substrate compressed and displaced the 
vascular structures in the mediastinum, primarily the 
aortic arch and its arterial branches toward the dorsal 
region. Pulmonary arteries were also suppressed. 
V.cava superior was suppressed as well towards the 
lateral region to the right, while its lumen was partially 
reduced. Pleural effusion was present bilaterally, more 
pronounced to the left side. Enlarged lymph nodes 
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were detected along the substrate in the proximal 
segment of the mediastinum. Enlarged lymph nodes 
were also detected bilaterally to the neck; the largest 
one was located to the right at the thyroid gland level, 
behind the right jugular vein (Figure 1). 
 
Figure 1: Computed tomography chest showing primary mediastinal 
seminoma with the involvement of major vessels 
 
Fine needle biopsy and core biopsy were 
performed on three occasions, whereby the results 
were obtained in two laboratories; one of the results 
had undefined histology, and it was in favour of 
lymphoma or a tumour of neural origin, while the 
histopathological finding by the second laboratory was 
in favour of a thymoma. A third opinion indicated a 
finding in favour of an extragonadal seminoma.  
Biochemical analyses were performed resulting in 
pronouncedly increased levels of LDH 1482 U/L 
(normal range of 0-225), alkaline phosphatase level of 
511 U/L (normal range of 40-129). Blood tests for 
germ cell tumour markers AFP were realised as well, 
with a normal level of 1.5 kiU/L and β-hCG with a 
pronouncedly increased level of 420.5 mlU/ml (normal 
range of 0-2.6). 
Considering the increased β-hCG level in 
correlation with the histopathological finding for 
extragonadal seminoma, examination of testicles was 
performed to detect an occult primary testicular 
tumour. Normal ultrasound finding was obtained. 
Before the treatment initiation due to worsening of the 
general condition and occurrence of pronounced 
fatigue and suffocating, the patient performed an 
ultrasound examination of the heart with a finding of 
pericardial effusion and threatening tamponade of the 
heart. Pericardiocentesis was performed, and 500 ml 
of haemorrhagic pericardial effusion were evacuated. 
The patient started chemotherapy by BEP protocol, 
and 4 cycles of chemotherapy were realised. 
Following 4 cycles of chemotherapy by BEP protocol, 
the patient normalised the levels of LDH and alkaline 
phosphatase, and β-hCG level as well; clinical 
condition of the patient was significantly improved and 
following the chemotherapy he did not have 
symptoms of the disease. 
After 4 weeks of the last chemotherapy cycle, 
the patient performed FDG-PET-CT scan; the result 
was in favour of partial response and presence of a 
pathologic metabolically active tumour substrate in the 
mediastinum. Radiotherapy for the residual tumour 
mass using IMRT technique was realised; a total dose 
of 40 Gy was achieved in the course of 20 fractions. 
The treatment was performed on LINAC by using X-
ray of 6 MV energy (Figure 2). The patient had no side 
effects related to the treatment during its realisation. 
 
Figure 2: Radiotherapy for the residual tumour mass is realised 
using IMRT technique; a total dose of 40 Gy 
 
Control FDG-PET-CT scan was performed 6 
weeks after the radiation therapy, and a finding of 
complete response to the treatment and absence of 
pathologic metabolic active tumour mass in the 
mediastinum was obtained (Figure 3). 
 
Figure 3: Comparative images from PET-CT before and after 
radiotherapy (upper part of a picture is PET-CT showing results 
after radiotherapy) 
 
The patient continued the regular follow-up 
examinations, and he was disease-free for 54 months 
since the initial diagnosis. The last follow-up 
examination performed in October 2018, had a normal 
finding and the patient was disease-free. 
 
 
Discussion 
 
Extragonadal germ cell tumours (GCTs) 
typically are located along the median line of the body, 
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including the mediastinal and retroperitoneal spaces. 
Mediastinal seminomas usually affect the anterior 
mediastinum involving the thymus; more rarely the 
tumour could be presented in the middle and the 
posterior mediastinum. In some cases, large tumours 
could expand from the anterior to the medium 
mediastinum and lead to difficulty in distinguishing the 
primary tumour localisation [3]. 
These extragonadal tumours are considered 
to develop from germ cell precursors trapped during 
the embryonic migration and survived on ectopic 
localisation. Approximately 90% of primary malignant 
mediastinal germ cell tumours develop in mail in the 
third decade of life. Metastatic disease occurs in less 
than half the cases; in case of occurrence, it is usually 
spread to adjacent lymph node groups in the neck, the 
mediastinum, or the abdomen. Hematogenous 
metastases are unusual but can be detected in the 
lungs, bones, liver, spleen, thyroid gland and brain. 
Primary mediastinal seminomas are 
manifested by non-specific symptoms. Symptoms are 
closely related to tumour localisation and dimensions. 
The most commonly reported symptoms include chest 
pain, dyspnea, cough, and weight loss [4]. The 
prognosis for pure seminomas in the mediastinum is 
excellent, with a 5-year survival rate in more than 90% 
using appropriate therapy. 
When a tumour mass in the mediastinum 
develops, it could be a metastatic or primary benign or 
malignant mediastinal tumour. Most common 
differentially diagnostic cases could be lymphoma, a 
tumour of neurogenic origin such as schwannoma; in 
case of the anterior mediastinum it could be a 
thymoma; if there are packages of lymph nodes, they 
could be metastatic deposits of primary lung 
carcinoma, or an extragonadal mediastinal seminoma 
or a non-seminoma tumour [5].  
Considering the difficult radiology distinction 
of these tumours, histopathological analysis of the 
biopsy material is necessary for definitive diagnosis. 
Another complicated step in the diagnosis of these 
tumours is the localisation, hardly accessible for 
biopsy. A biopsy can be done within the 
mediastinoscopy, or it could be CT-guided biopsy as 
in the case of our patient. There is significant 
morphological overlapping when it comes to 
embryonic carcinoma or seminoma, poorly 
differentiated carcinomas (such as pulmonary or 
thymus carcinoma, and metastatic carcinomas as 
well). Immunohistochemical analysis by a pathologist 
is of particular importance to specify the diagnosis by 
individual elimination of these entities. During the 
diagnosis of a germ cell tumour, a sample of blood 
may be collected to test for levels of serum tumour 
markers. High levels of any one of three tumour 
markers, called alpha-fetoprotein (AFP), beta human 
chorionic gonadotropin (β-hCG), and lactate 
dehydrogenase (LDH), may indicate a germ cell 
tumour. High AFP levels can also help identify the 
type of germ cell tumour, by showing whether it is a 
pure seminoma or mixed with non-seminoma, since 
AFP is not made by seminomas. However,  
β-hCG and LDH can be higher if a man has a 
seminoma, non-seminoma, or mixed tumour. The 
diagnosis in our case was based on the 
histopathological finding, as well as the biochemical 
analysis in favour of pronouncedly increased LDH and 
β-HCG levels. Monitoring of serum tumour markers is 
significantly important for the diagnosis and prognostic 
evaluation of patients with mediastinal seminoma.  
According to the 2010 American Society of 
Clinical Oncology clinical guidelines, in rare male 
patients presenting with testicular, retroperitoneal, or 
anterior mediastinal primary tumor and whose disease 
burden has resulted in an urgent need to start 
treatment, substantially elevated serum AFP and/or β- 
hCG may be considered sufficient for the diagnosis of 
GCT [6].
 
Patients at an early stage of mediastinal 
seminoma could be cured by surgical treatment and 
postoperative radiotherapy. Patients suffering from an 
advanced disease should be treated by chemotherapy 
and radiotherapy to achieve a good treatment result 
[7]. Seminoma is a highly radiosensitive tumour 
among mediastinal tumours, and therefore 
radiotherapy is considered an important treatment that 
increases the long-term survival rate of patients by 60-
80% [8]. Clinical trials have demonstrated excellent 
results when multimodality chemotherapy is combined 
with radiation for large, localised mediastinal 
seminomas or extensive residual disease [9].
 
 
In conclusion, multimodality treatment 
approach of chemotherapy followed by radiation 
consolidation ensured long-term survival in primary 
advanced mediastinal seminoma. 
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